Cramer Says Pfizer (PFE) Should Buy Allergan (AGN)

On Mad Money tonight, Jim Cramer said Pfizer (NYSE: PFE) should really take a strong look at buying Allergan (NYSE: AGN). Cramer thinks this is a smart play similar to Johnson & Johnson buying out Mentor Corporation (NYSE: MNT) earlier in the week.

Both Allergan and Mentor produce products that are used in cosmetic surgeries.

Additionally, Cramer liked that Allergan has a strong growth rate, whereas Pfizer has no growth. Therefore, if Pfizer makes a play for Allergan, it would get that much needed growth the Street covets.

In today's trading, Allergan closed at $36.20 and currently in the after-hours it is at $35.18.

Allergan, Inc. is a multi-specialty healthcare company focused on developing and commercializing pharmaceuticals, biologics and medical devices.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News!

You May Also Be Interested In

• Iran's foreign ministry spokesperson: geographic characteristics of the route in Strait of Hormuz agreed by Iran and Oman
• Demis Hassabis Stepping Down As Google Deepmind CEO To Be Chair - Bloomberg
• U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage